CAAS Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,633	Closed	-$115K	–	594
2021 Q4	$115K	Sell	25,633 -49,367	-66%	-$221K	﹤0.01%	304
2021 Q3	$626K	Buy	+75,000	New	+$626K	0.01%	304